A study analysing safety and effiacacy of combination of GEMOX and apatinib in treatment of unresectable or metastatic cholangiocellular carcinoma
Latest Information Update: 24 Jul 2020
At a glance
- Drugs Gemcitabine (Primary) ; Oxaliplatin (Primary) ; Rivoceranib (Primary)
- Indications Cholangiocarcinoma
- Focus Adverse reactions; Therapeutic Use
- 24 Jul 2020 New trial record
- 04 Jul 2020 Results presented at the 22nd World Congress on Gastrointestinal Cancer